Tresiba Inzulin

TRESIBA és súly gyarapodás:
"Weight gain can occur with insulin therapy, including TRESIBA, and has been attributed to the anabolic effects of insulin. In the clinical program after 52 weeks of treatment, patients with type 1 diabetes treated with TRESIBA gained an average of 1.8 kg and patients with type 2 diabetes treated with TRESIBA gained an average of 3.0 kg."
forrás: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203314lbl.pdf

FIASP és súly gyarapodás:
"Weight gain can occur with insulin therapy, including FIASP, and has been attributed to the anabolic effects of insulin and the decrease in glucosuria. In Study A, patients with type 1 diabetes treated with FIASP gained an average of 0.7 kg and in Study B, patients with type 2 diabetes treated with FIASP gained an average of 2.7 kg."
forrás: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208751s000lbl.pdf

Már egy másik topicban szerepelt a TRESIBA és a súly gyarapodás, de inkább ide tartozik, illetve a FIASP-ról még nem volt szó és hát ott is hasonló a helyzet.... :-(
 
Oldal tetejére